Advertisement

Neurological Sciences

, Volume 40, Issue 4, pp 879–882 | Cite as

Case report: hypertrophic pachymeningitis associated with Sjögren’s syndrome

  • Youngje Heo
  • Taewon KimEmail author
Letter to the Editor
  • 67 Downloads

Introduction

Sjögren syndrome (SS) is a systemic chronic autoimmune disorder characterized by lymphocytic infiltrates into the exocrine organs, particularly the parotid and lacrimal glands that results in typically distinct symptoms which manifest as xerophthalmia (dry eyes) and xerostomia (dry mouth). In addition, various organs could be involved with numerous extraglandular features, such as arthritis, Raynaud phenomenon, lymphoma, pulmonary disease, gastrointestinal disease, and neurological disease. Among the neurological diseases, sensory polyneuropathy is known to be the most common pattern, and mononeuropathy multiplex, polyradiculopathy, symptomatic dysautonomia, cranial neuropathy, myopathy, and central nervous system (CNS) involvement are less common [1].

The prevalence of CNS involvement in SS in a recent study was 67.5% [2]. However, a substantial variability in the reported prevalence exists because of the selection and referral bias [3]. Although the wide spectrum of CNS...

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Chai J, Logigian EL (2010) Neurological manifestations of primary Sjogren’s syndrome. Curr Opin Neurol 23(5):509–513.  https://doi.org/10.1097/WCO.0b013e32833de6ab CrossRefGoogle Scholar
  2. 2.
    Morreale M, Marchione P, Giacomini P, Pontecorvo S, Marianetti M, Vento C, Tinelli E, Francia A (2014) Neurological involvement in primary Sjogren syndrome: a focus on central nervous system. PLoS One 9(1):e84605.  https://doi.org/10.1371/journal.pone.0084605 CrossRefGoogle Scholar
  3. 3.
    Soliotis FC, Mavragani CP, Moutsopoulos HM (2004) Central nervous system involvement in Sjögren’s syndrome. Ann Rheum Dis 63(6):616–620.  https://doi.org/10.1136/ard.2003.019497 CrossRefGoogle Scholar
  4. 4.
    Nakano Y, Yamamoto M, Komatsu K, Yagita M, Fujita M (2018) Hypertrophic pachymeningitis in Sjogren’s syndrome. Intern Med 57(3):413–415.  https://doi.org/10.2169/internalmedicine.9406-17 CrossRefGoogle Scholar
  5. 5.
    Yonekawa T, Murai H, Utsuki S, Matsushita T, Masaki K, Isobe N, Yamasaki R, Yoshida M, Kusunoki S, Sakata K, Fujii K, Kira J (2014) A nationwide survey of hypertrophic pachymeningitis in Japan. J Neurol Neurosurg Psychiatry 85(7):732–739.  https://doi.org/10.1136/jnnp-2013-306410 CrossRefGoogle Scholar
  6. 6.
    Rossi S, Giannini F, Cerase A, Bartalini S, Tripodi S, Volpi N, Vatti G, Passero S, Galluzzi P, Ulivelli M (2004) Uncommon findings in idiopathic hypertrophic cranial pachymeningitis. J Neurol 251(5):548–555.  https://doi.org/10.1007/s00415-004-0362-y CrossRefGoogle Scholar
  7. 7.
    Kupersmith MJ, Martin V, Heller G, Shah A, Mitnick HJ (2004) Idiopathic hypertrophic pachymeningitis. Neurology 62(5):686–694CrossRefGoogle Scholar
  8. 8.
    Fujimoto M, Kira J, Murai H, Yoshimura T, Takizawa K, Goto I (1993) Hypertrophic cranial pachymeningitis associated with mixed connective tissue disease; a comparison with idiopathic and infectious pachymeningitis. Intern Med 32(6):510–512CrossRefGoogle Scholar
  9. 9.
    Ushiyama S, Kinoshita T, Shimojima Y, Ohashi N, Kishida D, Miyazaki D, Nakamura K, Sekijima Y, Ikeda SI (2016) Hypertrophic pachymeningitis as an early manifestation of relapsing polychondritis: case report and review of the literature. Case Rep Neurol 8(3):211–217.  https://doi.org/10.1159/000450850 CrossRefGoogle Scholar
  10. 10.
    Wallace ZS, Carruthers MN, Khosroshahi A, Carruthers R, Shinagare S, Stemmer-Rachamimov A, Deshpande V, Stone JH (2013) IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore) 92(4):206–216.  https://doi.org/10.1097/MD.0b013e31829cce35 CrossRefGoogle Scholar
  11. 11.
    Li JY, Lai PH, Lam HC, Lu LY, Cheng HH, Lee JK, Lo YK (1999) Hypertrophic cranial pachymeningitis and lymphocytic hypophysitis in Sjogren’s syndrome. Neurology 52(2):420–423CrossRefGoogle Scholar
  12. 12.
    Li S, Tang H, Rong X, Huang X, Li Q (2015) Pachymeningitis as a manifestation of ANCA-associated vasculitis: a care report and literature review. Int J Clin Exp Med 8(4):6352–6359Google Scholar
  13. 13.
    Huang Y, Chen J, Gui L (2017) A case of idiopathic hypertrophic pachymeningitis presenting with chronic headache and multiple cranial nerve palsies: a case report. Medicine (Baltimore) 96(29):e7549.  https://doi.org/10.1097/md.0000000000007549 CrossRefGoogle Scholar
  14. 14.
    Mamelak AN, Kelly WM, Davis RL, Rosenblum ML (1993) Idiopathic hypertrophic cranial pachymeningitis. Report of three cases. J Neurosurg 79(2):270–276.  https://doi.org/10.3171/jns.1993.79.2.0270 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia S.r.l., part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Neurology, College of Medicine, Incheon St Mary’s HospitalThe Catholic University of KoreaIncheonSouth Korea

Personalised recommendations